These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 36626635)

  • 1. Can a mucosal microbiota signature predict disease severity, survival, and disease recurrence in PSC?
    Hartmann P; Schnabl B
    Hepatology; 2023 Mar; 77(3):709-711. PubMed ID: 36626635
    [No Abstract]   [Full Text] [Related]  

  • 2. A shared mucosal gut microbiota signature in primary sclerosing cholangitis before and after liver transplantation.
    Hole MJ; Jørgensen KK; Holm K; Braadland PR; Meyer-Myklestad MH; Medhus AW; Reikvam DH; Götz A; Grzyb K; Boberg KM; Karlsen TH; Kummen M; Hov JR
    Hepatology; 2023 Mar; 77(3):715-728. PubMed ID: 36056902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intestinal microbiota in primary sclerosing cholangitis.
    Hov JR; Kummen M
    Curr Opin Gastroenterol; 2017 Mar; 33(2):85-92. PubMed ID: 28030369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Microbiome and Primary Sclerosing Cholangitis.
    Ali AH; Carey EJ; Lindor KD
    Semin Liver Dis; 2016 Sep; 36(4):340-348. PubMed ID: 27997974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Manipulation of the Gut-Liver Axis Using Microbiome Restoration Therapy in Primary Sclerosing Cholangitis.
    Bajaj JS; Hays RA
    Am J Gastroenterol; 2019 Jul; 114(7):1027-1029. PubMed ID: 30920413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut microbiome in primary sclerosing cholangitis: A review.
    Little R; Wine E; Kamath BM; Griffiths AM; Ricciuto A
    World J Gastroenterol; 2020 Jun; 26(21):2768-2780. PubMed ID: 32550753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the gut microbiota in patients with primary sclerosing cholangitis compared to inflammatory bowel disease and healthy controls.
    Ostadmohammadi S; Azimirad M; Houri H; Naseri K; Javanmard E; Mirjalali H; Yadegar A; Sadeghi A; Asadzadeh Aghdaei H; Zali MR
    Mol Biol Rep; 2021 Jul; 48(7):5519-5529. PubMed ID: 34304365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fungi participate in the dysbiosis of gut microbiota in patients with primary sclerosing cholangitis.
    Lemoinne S; Kemgang A; Ben Belkacem K; Straube M; Jegou S; Corpechot C; ; Chazouillères O; Housset C; Sokol H
    Gut; 2020 Jan; 69(1):92-102. PubMed ID: 31003979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The gut microbial profile in patients with primary sclerosing cholangitis is distinct from patients with ulcerative colitis without biliary disease and healthy controls.
    Kummen M; Holm K; Anmarkrud JA; Nygård S; Vesterhus M; Høivik ML; Trøseid M; Marschall HU; Schrumpf E; Moum B; Røsjø H; Aukrust P; Karlsen TH; Hov JR
    Gut; 2017 Apr; 66(4):611-619. PubMed ID: 26887816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered faecal microbiome and metabolome in IgG4-related sclerosing cholangitis and primary sclerosing cholangitis.
    Liu Q; Li B; Li Y; Wei Y; Huang B; Liang J; You Z; Li Y; Qian Q; Wang R; Zhang J; Chen R; Lyu Z; Chen Y; Shi M; Xiao X; Wang Q; Miao Q; Fang JY; Gershwin ME; Lian M; Ma X; Tang R
    Gut; 2022 May; 71(5):899-909. PubMed ID: 34035120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Pilot Integrative Analysis of Colonic Gene Expression, Gut Microbiota, and Immune Infiltration in Primary Sclerosing Cholangitis-Inflammatory Bowel Disease: Association of Disease With Bile Acid Pathways.
    Quraishi MN; Acharjee A; Beggs AD; Horniblow R; Tselepis C; Gkoutos G; Ghosh S; Rossiter AE; Loman N; van Schaik W; Withers D; Walters JRF; Hirschfield GM; Iqbal TH
    J Crohns Colitis; 2020 Jul; 14(7):935-947. PubMed ID: 32016358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Consistent alterations in faecal microbiomes of patients with primary sclerosing cholangitis independent of associated colitis.
    Rühlemann M; Liwinski T; Heinsen FA; Bang C; Zenouzi R; Kummen M; Thingholm L; Tempel M; Lieb W; Karlsen T; Lohse A; Hov J; Denk G; Lammert F; Krawczyk M; Schramm C; Franke A
    Aliment Pharmacol Ther; 2019 Sep; 50(5):580-589. PubMed ID: 31250469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of Microbiota in Primary Sclerosing Cholangitis and Related Biliary Malignancies.
    Özdirik B; Müller T; Wree A; Tacke F; Sigal M
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34203536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fecal Microbiota Transplantation in Patients With Primary Sclerosing Cholangitis: A Pilot Clinical Trial.
    Allegretti JR; Kassam Z; Carrellas M; Mullish BH; Marchesi JR; Pechlivanis A; Smith M; Gerardin Y; Timberlake S; Pratt DS; Korzenik JR
    Am J Gastroenterol; 2019 Jul; 114(7):1071-1079. PubMed ID: 30730351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting the Gut Microbiome as a Treatment for Primary Sclerosing Cholangitis: A Conceptional Framework.
    Shah A; Macdonald GA; Morrison M; Holtmann G
    Am J Gastroenterol; 2020 Jun; 115(6):814-822. PubMed ID: 32250997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gut microbiota in PSC : From association to possible causality. Commentary to "Gut pathobionts underlie intestinal barrier dysfunction and liver T helper 17 cell immune response in primary sclerosing cholangitis" by Nakamoto et al., Nature Microbiology, January 2019.
    Lemoinne S; Sabino J; Sokol H
    Clin Res Hepatol Gastroenterol; 2020 Apr; 44(2):123-125. PubMed ID: 31262571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations of the salivary and fecal microbiome in patients with primary sclerosing cholangitis.
    Lapidot Y; Amir A; Ben-Simon S; Veitsman E; Cohen-Ezra O; Davidov Y; Weiss P; Bradichevski T; Segev S; Koren O; Ben-Ari Z; Safran M
    Hepatol Int; 2021 Feb; 15(1):191-201. PubMed ID: 32949377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrence of primary sclerosing cholangitis after liver transplantation is associated with specific changes in the gut microbiome pretransplant - a pilot study.
    Visseren T; Fuhler GM; Erler NS; Nossent YRA; Metselaar HJ; IJzermans JNM; Darwish Murad S; Peppelenbosch MP
    Transpl Int; 2020 Nov; 33(11):1424-1436. PubMed ID: 33617049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevotella copri ameliorates cholestasis and liver fibrosis in primary sclerosing cholangitis by enhancing the FXR signalling pathway.
    Jiang B; Yuan G; Wu J; Wu Q; Li L; Jiang P
    Biochim Biophys Acta Mol Basis Dis; 2022 Mar; 1868(3):166320. PubMed ID: 34896545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The gut-adherent microbiota of PSC-IBD is distinct to that of IBD.
    Quraishi MN; Sergeant M; Kay G; Iqbal T; Chan J; Constantinidou C; Trivedi P; Ferguson J; Adams DH; Pallen M; Hirschfield GM
    Gut; 2017 Feb; 66(2):386-388. PubMed ID: 27196590
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.